Literature DB >> 28643230

Crosstalk between M2 macrophages and glioma stem cells.

Leora M Nusblat1, Molly J Carroll1,2, Charles M Roth3,4.   

Abstract

PURPOSE: Given its extremely poor prognosis, there is a pressing need for an improved understanding of the biology of glioblastoma multiforme (GBM), including the roles of tumor subpopulations that may contribute to their growth rate and therapy resistance. The most malignant phenotypes of GBM have been ascribed to the presence of subpopulations of cancer stem cells (CSCs), which are resistant to chemotherapeutic drugs and ionizing radiation and which promote invasiveness and metastasis. The mechanisms by which the CSC state is obtained and by which it promotes tumor maintenance are only beginning to emerge. We hypothesize that M2 polarized macrophages may affect CSC phenotypes via cell-cell communication.
METHODS: We investigated the interplay between glioma CSCs and macrophages via co-culture. The invasiveness of CSCs in the absence and presence of macrophages was assessed using collagen degradation and Transwell migration assays. The role of STAT3 as a CSC phenotypic mediator was assessed using siRNA-mediated gene silencing.
RESULTS: We found that the levels of a M2 macrophage-specific secreted cytokine, TGF-β1, were elevated in the presence of CSCs, regardless of whether the cells were plated as contacting or non-contacting co-cultures. In addition, we found that the co-culture resulted in enhanced expression of M2 markers in macrophages that were previously polarized to the M1 phenotype. siRNA-mediated STAT3 silencing was found to reduce the chemo-responsiveness and migratory abilities of the CSCs. Combination treatment of STAT3 siRNA and DNA alkylating agents was found to further abrogate CSC functions.
CONCLUSIONS: Our data indicate that the co-culture of CSCs and macrophages results in bi-directional signaling that alters the phenotypes of both cell types. These results provide an explanation for recently observed effects of macrophages on GBM tumor cell growth, motility and therapeutic resistance, and suggest potential therapeutic strategies to disrupt the CSC phenotype by impairing its communication with macrophages.

Entities:  

Keywords:  Cancer stem cell; Glioblastoma multiforme; Macrophage; STAT3; siRNA

Mesh:

Substances:

Year:  2017        PMID: 28643230     DOI: 10.1007/s13402-017-0337-5

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  58 in total

1.  Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL).

Authors:  Daisuke Niino; Yoshihiro Komohara; Toshihiko Murayama; Ryosuke Aoki; Yoshizo Kimura; Keiko Hashikawa; Junichi Kiyasu; Masanori Takeuchi; Nobuko Suefuji; Yasuo Sugita; Motohiro Takeya; Koichi Ohshima
Journal:  Pathol Int       Date:  2010-04       Impact factor: 2.534

2.  STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?

Authors:  Claire Villalva; Severine Martin-Lannerée; Ulrich Cortes; Fatima Dkhissi; Michel Wager; Amélie Le Corf; Jean-Marc Tourani; Isabelle Dusanter-Fourt; Ali G Turhan; Lucie Karayan-Tapon
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

Review 3.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.

Authors:  Marco Prinz; Josef Priller
Journal:  Nat Rev Neurosci       Date:  2014-04-09       Impact factor: 34.870

Review 4.  Immunotherapy targeting glioma stem cells--insights and perspectives.

Authors:  Zhenhua Li; Jang-Won Lee; Debraj Mukherjee; Jianfei Ji; Sunil P Jeswani; Keith L Black; John S Yu
Journal:  Expert Opin Biol Ther       Date:  2011-12-26       Impact factor: 4.388

Review 5.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 6.  Glioma stem cell maintenance: the role of the microenvironment.

Authors:  John M Heddleston; Masahiro Hitomi; Monica Venere; William A Flavahan; Kenneth Yang; Youngmi Kim; Sana Minhas; Jeremy N Rich; Anita B Hjelmeland
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

7.  Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation.

Authors:  Eduard H Panosyan; Dan R Laks; Michael Masterman-Smith; Jack Mottahedeh; William H Yong; Timothy F Cloughesy; Jorge A Lazareff; Paul S Mischel; Theodore B Moore; Harley I Kornblum
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

8.  Importance of direct macrophage-tumor cell interaction on progression of human glioma.

Authors:  Yoshihiro Komohara; Hasita Horlad; Koji Ohnishi; Yukio Fujiwara; Bing Bai; Takenobu Nakagawa; Shinya Suzu; Hideo Nakamura; Jun-ichi Kuratsu; Motohiro Takeya
Journal:  Cancer Sci       Date:  2012-10-26       Impact factor: 6.716

9.  Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.

Authors:  Trine O Jensen; Henrik Schmidt; Holger Jon Møller; Morten Høyer; Maciej Bogdan Maniecki; Pia Sjoegren; Ib Jarle Christensen; Torben Steiniche
Journal:  J Clin Oncol       Date:  2009-06-15       Impact factor: 44.544

Review 10.  Cancer stem cell contribution to glioblastoma invasiveness.

Authors:  Barbara Ortensi; Matteo Setti; Daniela Osti; Giuliana Pelicci
Journal:  Stem Cell Res Ther       Date:  2013-02-28       Impact factor: 6.832

View more
  26 in total

Review 1.  Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.

Authors:  Gustav van Niekerk; Anna-Mart Engelbrecht
Journal:  Cell Oncol (Dordr)       Date:  2018-05-24       Impact factor: 6.730

2.  The role of TNF-α in chordoma progression and inflammatory pathways.

Authors:  Sukru Gulluoglu; Emre Can Tuysuz; Mesut Sahin; Cumhur Kaan Yaltirik; Aysegul Kuskucu; Ferda Ozkan; Altay Burak Dalan; Fikrettin Sahin; Ugur Ture; Omer Faruk Bayrak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-07       Impact factor: 6.730

3.  BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.

Authors:  Bo Wang; Chen Cao; Xi Liu; Xin He; Hao Zhuang; Dong Wang; Budong Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-27       Impact factor: 6.730

4.  QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.

Authors:  Bo Han; Ruijia Wang; Yongjie Chen; Xiangqi Meng; Pengfei Wu; Ziwei Li; Chunbin Duan; Qingbin Li; Yang Li; Shihong Zhao; Chuanlu Jiang; Jinquan Cai
Journal:  Cell Oncol (Dordr)       Date:  2019-07-10       Impact factor: 6.730

5.  Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.

Authors:  Xue-Jing Shao; Sen-Feng Xiang; Ying-Qian Chen; Ning Zhang; Ji Cao; Hong Zhu; Bo Yang; Qian Zhou; Mei-Dan Ying; Qiao-Jun He
Journal:  Acta Pharmacol Sin       Date:  2019-07-11       Impact factor: 6.150

6.  Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.

Authors:  Shasha Liu; Chaoqi Zhang; Nomathamsanqa Resegofetse Maimela; Li Yang; Zhen Zhang; Yu Ping; Lan Huang; Yi Zhang
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

Review 7.  Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.

Authors:  Federico Rossari; Cristina Zucchinetti; Gabriele Buda; Enrico Orciuolo
Journal:  Cell Oncol (Dordr)       Date:  2019-08-07       Impact factor: 6.730

Review 8.  Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.

Authors:  Meysam Yousefi; Rahim Nosrati; Arash Salmaninejad; Sadegh Dehghani; Alireza Shahryari; Alihossein Saberi
Journal:  Cell Oncol (Dordr)       Date:  2018-03-22       Impact factor: 6.730

9.  Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN.

Authors:  Bin Wang; Zhong-Hua Wu; Ping-Yang Lou; Chang Chai; Shuang-Yin Han; Jian-Fang Ning; Ming Li
Journal:  Cell Oncol (Dordr)       Date:  2019-07-22       Impact factor: 6.730

10.  Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17.

Authors:  Wangmi Liu; Xiankuan Xie; Jiayan Wu
Journal:  Cell Oncol (Dordr)       Date:  2019-12-12       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.